|Brand name(s), other common name(s)||Vumon®, VM-26|
|Drug type||DNA-repair enzyme inhibitor|
|How the drug is given||Intravenously (IV)|
Indications and Usage
Teniposide is FDA approved along with other medicines as induction therapy to treat people who have refractory childhood acute lymphoblastic leukemia, non-Hodgkin lymphoma and other types of cancer. This medicine often causes a temporary loss of hair. After treatment with teniposide has ended, normal hair growth should return.
Side effects needing medical attention
Chills (severe); fever; hives; palpitations; difficulty breathing; dizziness; weakness; facial flushing; unusual tiredness or fatigue; unusual bruising or bleeding; rash; sores on mouth or lips; diarrhea; nausea; vomiting. It is important to tell your healthcare provider right away if redness, pain, swelling or a lump under the skin occurs in the area where the injection is given.
For information on how to manage the costs of drug therapy, please see Financial Support, or to speak with an Information Specialist, call (800) 955-4572.